Skip to main content Back to Top

ASHP Policy Position 0814

FEDERAL REVIEW OF ANTICOMPETITIVE PRACTICES BY DRUG PRODUCT MANUFACTURERS (Superseded)

Status: Superseded

This policy position supersedes ASHP policy position 0520.

Superseded by ASHP policy position 1818.